PT-141
$114.00 Original price was: $114.00.$98.00Current price is: $98.00.
PT-141 is studied in laboratory research for its interaction with melanocortin receptor systems, particularly in models examining neurological signaling pathways, receptor modulation, and central signaling integration. Research focuses on ligand–receptor dynamics and downstream neural pathway behavior.
- Size
- 10 mg
- Form
- Lyophilized powder, sealed vial
- Purity
- 99%+
- Storage
- Cool, dry & dark · −20°C long-term
- Intended use
- Laboratory research only
In stock (can be backordered)
PT-141 Research Overview
PT-141 (bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist derived from Melanotan-II, with activity primarily at the MC4R and MC3R receptors.
PT-141 has been researched primarily for its action on central melanocortin signaling pathways in the brain. Rodent studies have examined its effects on appetitive and solicitational behaviors, and it has been evaluated in clinical development programs studying central melanocortin pathways.
Related research compounds: Melanotan-II (MT-2)
Important Notice
PT-141 is provided strictly for research use only. It is not intended for human or animal use, clinical purposes, diagnostic work, or consumption. Qualified professionals must conduct all research in proper laboratory environments and in compliance with applicable regulations and guidelines.
Product Form & Stability
This research compound is supplied in a lyophilized (freeze-dried) powder format, an industry-standard preparation method designed to support long-term stability and structural integrity during storage and transport.
Lyophilization removes moisture while preserving the molecular characteristics of the compound, helping to maintain consistency for laboratory research applications.
Preparation for Research Use
Before laboratory use, the lyophilized material must be reconstituted using an appropriate research-grade sterile solvent (not included).
Proper reconstitution supports accurate concentration control and repeatability within experimental settings.
No instructions regarding administration or use outside of laboratory research are provided.
Research Use Only
This product is intended exclusively for laboratory, analytical, and in-vitro research purposes.
It is not approved for human or veterinary use, diagnostic procedures, or therapeutic applications of any kind.
Handling and use should be performed only by qualified professionals within a controlled research environment.
Storage & Handling
- Store in a cool, dry location, protected from light
- If reconstituted, refrigeration is recommended
- For extended storage, freezing at −20°C may help preserve compound integrity
- Proper storage conditions are the responsibility of the purchaser
Product Notes
All vial products sold by Thrive Biolab LLC are shipped in lyophilized or original powder form and require reconstitution prior to laboratory testing.
We are unable to provide guidance related to dosing, administration, or any use outside of research contexts.
Products are manufactured and supplied with a focus on purity, consistency, and documentation suitable for research applications.
Intended Use Disclaimer
All products offered on this website are provided solely for research and development purposes and are not for human or animal consumption.
Statements on this website have not been evaluated by the U.S. Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure, or prevent any disease.
Company Disclosure
Thrive Biolab LLC operates as a research chemical supplier.
We are not a compounding pharmacy under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor are we an outsourcing facility under Section 503B of the Act.
All products are sold strictly for laboratory, analytical, and research use only.
The peer-reviewed publications below are indexed on PubMed and provided for scientific reference only. Their inclusion does not suggest that this product is intended for any use described in them. All products are sold strictly for laboratory research use.
PT-141 (Bremelanotide)
- PT-141: a melanocortin agonist for the treatment of sexual dysfunctionAnn N Y Acad Sci, 2003 · PMID 12851303
- Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonistProc Natl Acad Sci U S A, 2004 · PMID 15226502
- Bremelanotide: First ApprovalDrugs, 2019 · PMID 31429064
